CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)

Ashley Horne, Aaisha Ali, Sarah Brown, Karl Butterworth, Anthony Chalmers, Alexandra Clipson, Fiona Collinson, Caroline Dive, Corinne Faivre-Finn, Martin Forster, Kevin Franks, Alexandra Gilbert, Gerry Hanna, Nicola Hannaway, Stephen Harrow, John Hartley, Crispin Hiley, Robert Jones, Jessica Kendall, Matthew KrebsGeorgia Mallison, James O’Connor, Jamie Oughton, Rachel Phillip, Dominic Rothwell, Ahmed Salem, David Sebag-Montefiore, Paul Shaw, Gerard Walls, Robin Young, Alastair Greystoke

Research output: Contribution to journal › Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science